Literature DB >> 16683046

Inclusion proteins of Chlamydiaceae.

Y Pannekoek1, A van der Ende.   

Abstract

Chlamydiaceae are obligate intracellular pathogens with family members among the etiological agents of several human diseases, such as blinding trachoma, sexually transmitted disease (Chlamydia trachomatis) and pneumonia (Chlamydophila pneumoniae, Chlamydophila psittaci). The bacteria replicate intracellularly in a membrane-bound vacuole termed inclusion. The chlamydial inclusion is effectively separated from eukaryotic endocytic pathways. More than two decades ago it was already speculated that Chlamydiae might modify the inclusion membrane through the insertion of chlamydial-derived components. However, because the classical genetic approaches cannot be applied to manipulate these bacteria, it took more than 10 years before definitive proof was obtained that Chlamydiae indeed actively modify the inclusion membrane by the insertion of proteins of chlamydial origin, first observed by Rockey et al. in 1995. This review will focus on the structural and functional aspects of inclusion proteins of Chlamydiaceae, thereby summarizing data obtained by in vitro studies and comparative genomics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16683046

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  2 in total

1.  Microscopic Analysis of the Chlamydia abortus Inclusion and Its Interaction with Those Formed by Other Chlamydial Species.

Authors:  Lotisha E Garvin; Addison G DeBoer; Steven J Carrell; Xisheng Wang; Daniel D Rockey
Journal:  Infect Immun       Date:  2022-01-31       Impact factor: 3.609

2.  Whole genome de novo sequencing and comparative genomic analyses suggests that Chlamydia psittaci strain 84/2334 should be reclassified as Chlamydia abortus species.

Authors:  David Longbottom; Morag Livingstone; Paolo Ribeca; Delphine Sylvie Anne Beeckman; Arie van der Ende; Yvonne Pannekoek; Daisy Vanrompay
Journal:  BMC Genomics       Date:  2021-03-06       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.